The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
Abstract
Objective. To assess the frequency of methotrexate (MTX)‐induced pancytopenia in rheumatoid arthritis (RA). Methods. A MEDLINE literature search was conducted to identify articles published during the last 15 years (1980–1995) that presented data on MTX‐associated pancytopenia. Two case reports of our own experience are also presented. In addition, articles that examined risk factors associated with MTX‐related pancytopenia were identified. Results. A total of 70 patients with pancytopenia related to MTX therapy were identified (68 reported in the literature, 2 from our own experience). Sixty‐one of the patients were described in published case reports, 7 patients were from 5 long‐term prospective studies. In many of these cases, predisposing factors for the development of pancytopenia were described. The 5 long‐term prospective studies reported toxicity data on patients who had been treated with MTX for at least 13 weeks. A total of 511 patients were included in the prospective trials, yielding an overall incidence of pancytopenia of 1.4% (7 of 511). Of the 70 cases reported, 12 patients died (17%). Most of them had impaired renal function, hypoalbuminemia, concurrent infection, and/or concomitant medication with more than 5 drugs. The minimal cumulative MTX dose leading to fatal pancytopenia was 10 mg, observed in one of our patients. Conclusion. Pancytopenia is not an uncommon side effect of low‐dose pulse MTX therapy in RA. It can lead to serious complications, including death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Williams, H. J., Willkens, R. F., Samuelson, C. O., Alarcón, G. S., Guttadauria, M., Yarboro, C., Polisson, R. P., Weiner, S. R., Luggen, M. E., Billingsley, L. M., et al. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280702 · Cited by 462
ANDERSEN, P. A., WEST, S. G., O'DELL, J. R., VIA, C. S., CLAYPOOL, R. G., & KOTZIN, B. L. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-489 · Cited by 331
Textbook of Adverse Drug Reactions
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-1072_3 · Cited by 160
Toxicity of low dose methotrexate in rheumatoid arthritis.
Weinblatt, M. E. (1985) · PubMed · Cited by 151
Toxicity of methotrexate in rheumatoid arthritis.
Gispen, J. G., Alarcón, G. S., Johnson, J. J., Acton, R. T., Barger, B. O., & Koopman, W. J. (1987) · PubMed · Cited by 113
Methotrexate and trimethoprim-sulphamethoxazole-a potentially hazardous combination
Groenendal, H., & Rampen, F. H. J. (1990) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.1990.tb02113.x · Cited by 74
Post-marketing surveillance: how many patients?
Lewis, J. A. (1981) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(81)90275-3 · Cited by 70
Cornelissen, J. J., Bakker, L. J., van der Veen, M. J., Rozenberg-Arska, M., & Bijlsma, J. W. J. (1991) · Annals of the Rheumatic Diseases · doi:10.1136/ard.50.9.642 · Cited by 43
Cited by
Greb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Salliot, C., & van der Heijde, D. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.093690 · Cited by 673
Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review
Wang, W., Zhou, H., & Liu, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.027 · Cited by 562
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.027 · Cited by 558
Metadata
- Authors
- Gutierrez‐Ureña, S., Molina, J. F., García, C. O., Cuéllar, M. L., & Espinoza, L. R.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1996-02
- Volume
- 39
- Issue
- 2
- Pages
- 272-276
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2020033130
- Cited by
- 279
- References
- 9
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. https://app.cochat.ai/papers/10.1002/art.1780390214
- The paper
- Gutierrez‐Ureña, S., Molina, J. F., García, C. O., Cuéllar, M. L., & Espinoza, L. R. (1996). Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780390214
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.